CUMBERLAND PHARMACEUTICALS INC Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Cumberland Pharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2010 to Q3 2024.
  • Cumberland Pharmaceuticals Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 14.1M shares, a 1.57% decline year-over-year.
  • Cumberland Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 14.3M shares, a 1.82% decline from 2022.
  • Cumberland Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 14.6M shares, a 2.29% decline from 2021.
  • Cumberland Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 14.9M shares, a 1.7% decline from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 14.1M -224K -1.57% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 14.1M -276K -1.92% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 14.1M -261K -1.82% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 14.3M -265K -1.82% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 14.3M -200K -1.38% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 14.4M -295K -2.01% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 14.4M -332K -2.26% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 14.6M -341K -2.29% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 14.5M -403K -2.71% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 14.7M -288K -1.92% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 14.7M -283K -1.89% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 14.9M -257K -1.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-13
Q3 2021 14.9M -254K -1.68% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 15M -265K -1.74% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 15M -266K -1.75% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 15.2M -234K -1.52% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 15.1M -233K -1.52% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 15.2M -282K -1.82% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 15.2M -232K -1.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 15.4M -218K -1.4% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-11
Q3 2019 15.4M -205K -1.32% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 15.5M -151K -0.97% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 15.5M -216K -1.38% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-22
Q4 2018 15.6M -298K -1.87% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-12
Q3 2018 15.6M -294K -1.85% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 15.7M -337K -2.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 15.7M -353K -2.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 15.9M -325K -2% Oct 1, 2017 Dec 31, 2017 8-K 2020-12-10
Q3 2017 15.9M -350K -2.16% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 16M -235K -1.45% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 16M -299K -1.83% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 16.2M -479K -2.87% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-12
Q3 2016 16.2M -387K -2.33% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 16.2M -574K -3.41% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 16.3M -671K -3.95% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 16.7M -902K -5.12% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-09
Q3 2015 16.6M -940K -5.36% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 16.8M -923K -5.2% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 17M -895K -5% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 17.6M -715K -3.9% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-13
Q3 2014 17.5M -689K -3.78% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 17.7M -662K -3.6% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 17.9M -851K -4.53% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 18.3M -1.23M -6.3% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-14
Q3 2013 18.2M -1.2M -6.17% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 18.4M -1.37M -6.91% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 18.8M -1.25M -6.25% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 19.6M -778K -3.83% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-09
Q3 2012 19.4M -895K -4.4% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-06
Q2 2012 19.8M -700K -3.42% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 20M -438K -2.14% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 20.3M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-11
Q3 2011 20.3M -330 0% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-02
Q2 2011 20.5M +26.1K +0.13% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 20.4M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-04
Q3 2010 20.3M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 20.4M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.